07-May-2009 - Merck KGaA

Antaria and Merck sign licensing agreement

Merck KGaA announced it has executed a licensing agreement with Antaria Limited, Australia, for the exclusive worldwide rights to Antaria’s plate-like alumina technology.

The technology from Antaria is used in Alusion®, a functional filler that gives cosmetics soft focus properties, among other applications. Under the agreement, Merck has exclusive rights to manufacture and sell products using this technology in cosmetic and technical applications. During the initial period of the license, Antaria will toll manufacture Alusion® and other products for Merck and also provide contract research and development on a fee-for-service basis.

Dr. Alois Seidl, responsible for Merck’s global Pigments business said: “With Antaria’s technology, we can significantly expand our portfolio in both the cosmetic functional fillers sector as well as in the core pearlescent pigments business.”

Facts, background information, dossiers
More about Merck
More about Antaria